A group of researchers from the Institute of Health Carlos III (ISCIII) in Spain, presented a poster at the annual meeting for the International Society of Extracellular Vesi
Cell therapy using cardiosphere-derived cells (CDCs) is an increasingly promising treatment for acute and congenital heart muscle injuries, including myocardial infarction (MI).